Peptide record

TPDB44201

Antiviral standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB44201
Antiviral
Anti-infective peptides
AI4AVP DRAVP 2.0 Peptipedia
standard
No
A 15-aa standard-residue antiviral peptide sequence curated from AI4AVP, DRAVP 2.0, and Peptipedia, with an available 3D structural model.
Sequence
AFHRYGTTVNCIVEE
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C76H115N21O24S1
DQLKMPSW
ETV
1738.94
5.30
2
2
6
-1
1.67
-0.087
71.33
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
1490
0.86
5
Residue Composition
number
1
A
1
R
1
N
0
D
1
C
2
E
0
Q
1
G
1
H
1
I
0
L
0
K
0
M
1
F
0
P
0
S
2
T
0
W
1
Y
2
V
Amino Acid Distribution
A: 1 R: 1 N: 1 D: 0 C: 1 E: 2 Q: 0 G: 1 H: 1 I: 1 L: 0 K: 0 M: 0 F: 1 P: 0 S: 0 T: 2 W: 0 Y: 1 V: 2
Chemical Descriptors
15 reviewed residue count
C76H115N21O24S1 sequence-only estimate (linear, free termini)
1738.94 sequence-only estimate (linear, free termini)
5.30 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
1.67 sequence-only estimate (linear, free termini)
-0.087 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0